Medical Economics February 13, 2025
Richard Payerchin

Bargaining for widely used prescription drugs may save money for Medicare, but AAR wants seniors to see better prices at the pharmacy counter.

The Alliance for Aging Research (AAR), based in Washington, D.C., has grown to become a leading patient advocacy organization. The Alliance also works with federal agencies, elected officials and partner organizations “to advance policies that support research and health aging.” Adina Lasser is director of public policy and government affairs for the Alliance. While many have praised the Medicare Drug Price Negotiation Program as a means to help beneficiaries, AAR has questioned whether the main motive is to save money for Medicare. In this video series, Lasser explains that distinction and what it means for patients.

Medicare...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Conferences / Podcast, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Trends
Value-based payment models: Doctors describe the disconnect between theory and practice
Nurse anesthetists outnumber anesthesiologists billing Medicare
OIG report finds just 40% of Medicare enrollees who started treatment for opioid use disorder continued
Fewer psychiatrists are billing Medicare: 5 things to know
Psychiatrists participating in Medicare Part B declines: Study

Share This Article